CBS and myeloid sarcoma: It was previously found that H2S levels and CBS activity in astrocytes decrease significantly in patients with neurological diseases [e.g., AD, Parkinson’s disease (PD), and MS], while the restoration of H2S levels or the enhancement of CBS activity in the brain exerts neuroprotective effects by alleviating neuroinflammation [18, 19].